LinusBio

NEWS

Map of NextGen Class of 2024/BioSpace

Business

NextGen Class of 2024: Top Life Sciences Startups to Watch This Year

Rapport Therapeutics tops this year’s list with $250 million in Series A and B financing in just six months.

January 3, 2024

·

20 min read

·

BioSpace Editorial Staff

IN THE PRESS

Press Releases

Groundbreaking Autism Biomarker: LinusBio Launches ClearStrand-ASD to aid Health Care Providers in Ruling Out Autism Using a Single Strand of Hair

February 6, 2025

·

4 min read

Pharm Country

Semaphore Solutions’ Labbit Laboratory Informatics Solution Plays a Pivotal Role in Enhancing LinusBio’s Innovative Diagnostic Platform, Following LinusBio’s $25.5 Million Series A Funding Round

October 26, 2023

·

3 min read

AWARDS

JOBS